The Patent Finder

Domain Therapeutics SA

Also on record
Records under this name other than the patents Domain Therapeutics SA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 5 of 5 · Back to Domain Therapeutics SA

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,194,0515-Azaindazole Derivatives as Adenosine Receptor Antagonists
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,008,323Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors
Formerly held
Lapsed on the fee record
Ended May 18, 2025 · USPTO record
Lapsed on the fee recordEnded May 18, 2025USPTO record
US 10,221,179Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
Lapsed on the fee record
Ended Mar 5, 2023 · USPTO record
Lapsed on the fee recordEnded Mar 5, 2023USPTO record
US 8,962,627Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
Formerly held
Lapsed on the fee record
Ended Feb 24, 2023 · USPTO record
Lapsed on the fee recordEnded Feb 24, 2023USPTO record
US 9,434,734Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
Lapsed on the fee record
Ended Sep 6, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 6, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited